a
Chair of Biophysics, Faculty of Biology and Biotechnology Ruhr University Bochum, Germany
E-mail:gerwert@bph.rub.de

b
Institute of Pathology, Ruhr University Bochum, Germany

Abstract

In recent years spectral histopathology (SHP) has been established as a label-free method to identify cancer within tissue. Herein, this approach is extended. It is not only used to identify tumour tissue with a sensitivity of 94% and a specificity of 100%, but in addition the tumour grading is determined. Grading is a measure of how much the tumour cells differ from the healthy cells. The grading ranges from G1 (well-differentiated), to G2 (moderately differentiated), G3 (poorly differentiated) and in rare cases to G4 (anaplastic). The grading is prognostic and is needed for the therapeutic decision of the clinician. The presented results show good agreement between the annotation by SHP and by pathologists. A correlation matrix is presented, and the results show that SHP provides prognostic values in colon cancer, which are obtained in a label-free and automated manner. It might become an important automated diagnostic tool at the bedside in precision medicine.

For reproduction of material from NJC:
[Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the
Centre National de la Recherche Scientifique (CNRS) and the RSC.

For reproduction of material from PCCP:
[Original citation] - Published by the PCCP Owner Societies.

For reproduction of material from PPS:
[Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the
European Society for Photobiology, the European Photochemistry Association, and
RSC.

For reproduction of material from all other RSC journals:
[Original citation] - Published by The Royal Society of Chemistry.

Information about reproducing material from RSC articles with different licences
is available on our Permission Requests page.